Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001209191-23-020477 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-22 | 2023-03-20 | YARW | Harsch Mutya | CLO, GC | P - Purchase | $2.50 | +10.0K | 22.7K | +79% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | P | A | 10,000 | $2.50 | 22,721 | D | — | — | (F1) On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. |